eCPR Review Highlights Benefits, Ethical Challenges

Evidence suggests improved outcomes in selected patients with cardiac arrest, but limited data, complications, and resource demands may restrict broader use.

By
Andrea Surnit
April 21, 2026
4 min

Conexiant

Overview

Extracorporeal cardiopulmonary resuscitation (eCPR) shows promise in improving survival and neurologic outcomes in selected cardiac arrest patients, though evidence remains limited and heterogeneous. The review highlights significant ethical, resource, and access challenges associated with broader eCPR implementation.

Background

Extracorporeal cardiopulmonary resuscitation (eCPR) involves the use of extracorporeal membrane oxygenation during resuscitation for refractory cardiac arrest. It is increasingly studied as a potential intervention to improve survival and neurologic recovery compared to conventional cardiopulmonary resuscitation (CPR). However, most data come from specialized centers, limiting generalizability. Additionally, eCPR requires specialized teams and intensive care resources, raising concerns about equitable access and ethical considerations.

Data Highlights

Outcome	eCPR	Conventional CPR
Survival with favorable neurologic status	14%	7%
Neurologically favorable survival within 29 minutes	100% (selected cohort)	24%
Bleeding complications	8%–70%	Not reported
Infections	8%–22%	Not reported
Limb ischemia	3%–15%	Not reported
Neurologic death criteria met	~10%	Not reported

Key Findings

eCPR is associated with improved survival to hospital discharge and at 30 and 180 days compared with conventional CPR, though results vary by study design and patient population.
A meta-analysis of 14,048 patients showed better short-term neurologic outcomes and higher 30-day survival with eCPR.
Earlier initiation of eCPR correlates with improved neurologic recovery; one study showed 100% neurologically favorable survival when started within 29 minutes.
Complications such as bleeding (8%–70%), infections (8%–22%), and limb ischemia (3%–15%) are common and contribute to morbidity and mortality.
Ethical and system-level challenges include limited access due to resource intensity, potential exacerbation of healthcare disparities, and concerns about organ donation influencing treatment decisions.
Family impact includes prolonged emotional distress and uncertainty; quality of life data remain limited and inconclusive.

Clinical Implications

Clinicians should consider eCPR as a potential option for selected patients with refractory cardiac arrest, recognizing the importance of early initiation to optimize neurologic outcomes. Careful patient selection, ethical reflection, and resource availability must guide its use to avoid inequities and unintended consequences. Ongoing evaluation of long-term neurologic function and quality of life is needed to inform practice.

Conclusion

eCPR offers promising survival and neurologic benefits in select cardiac arrest patients but is accompanied by significant ethical, logistical, and clinical challenges. Responsible, patient-centered application and further rigorous research are essential for its integration into resuscitation protocols.